13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Memory and Trauma Care
Memory and trauma care encompasses the psychological realm dedicated to addressing and healing the deep-seated wounds inflicted by traumatic experiences. Such events can profoundly impact an individual's memory, often manifesting in symptoms like flashbacks, nightmares, and intrusive thoughts. Trauma can fracture or distort memory, complicating the processing and understanding of these experiences. Effective trauma care employs a variety of therapeutic approaches, such as cognitive-behavioral therapy (CBT), eye movement desensitization and reprocessing (EMDR), and narrative therapy. These techniques aid in the processing and reframing of memories, diminishing the intensity of emotional responses and facilitating integration into one's life narrative. Central to trauma care is the establishment of a safe and supportive environment wherein individuals can explore and express their emotions. Building trust with a therapist or support group, developing coping strategies, and fostering resilience are vital components of this process. Ultimately, memory and trauma care are instrumental in helping individuals recover from traumatic events, empowering them to navigate life with newfound resilience and understanding.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States